Elanco Animal Health (ELAN) news

Neurizon Therapeutics Ltd-Elanco representative appointed as Neurizon board observer

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) has announced appointment of Ms Justine Conway as a Board Observer, effective November 26, 2025. Ms Conway currently serves as Global Head of Business Development at Elanco Animal Health (NYSE: ELAN) and will represent Elanco in…

Elanco Animal Health Inc outlook Q3 adj EPS $0.19 - $0.22

Elanco Animal Health shares up 6.5% premarket after Q2 results beat

Elanco Animal Health (NYSE: ELAN) shares rose 6.5% in premarket trading following the release of its second-quarter financial results, which exceeded expectations. The company reported stronger-than-anticipated earnings, driven by solid performance across its product portfolio and operational…

Elanco Animal Health Inc: expects tailwind to revenue of about $60 mln from favorable impact of foreign exchange rates compared to prior year

Elanco Animal Health Inc. (NYSE: ELAN) reported first-quarter 2026 results that demonstrated strong financial performance and upward revisions to its full-year guidance. The company expects a tailwind to revenue of approximately $60 million from the favorable impact of foreign exchange rates…

Elanco shares gain 5.5% after boosting FY earnings forecast

Elanco Animal Health’s shares rose 5.5% following the company’s announcement of an upward revision to its full-year earnings forecast. The adjustment reflects stronger-than-expected performance in the first quarter of 2026, with earnings per share (EPS) exceeding analyst estimates. The company…